Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,380 across all filing types
Latest filing 2014-05-06 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2014-05-06 English
Monthly Return
Major Shareholding Notification Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/04/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a Major Shareholding Notification or similar capital movement report. Given the detailed share capital movement data and the nature of the document, it fits best under the category Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or share capital movements. The document is not an announcement of a report but a detailed monthly return, so it is not RPA or RNS. Therefore, the classification is MRQ with high confidence.
2014-05-05 English
UPDATE ON A LITIGATION INVOLVING YANZHOU COAL MINING COMPANY LIMITED
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding an update on a litigation involving Yanzhou Coal Mining Company Limited. It references specific legal proceedings, the judgment of the first instance court, and the potential impact on company profits. The document is relatively short (3613 characters) and focuses on legal matters rather than financial results or management commentary. It does not contain financial statements or detailed financial analysis, nor does it announce voting results, capital changes, or management changes. The content fits the description of a Legal Proceedings Report, which provides updates on significant lawsuits or regulatory actions involving the company. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2014-04-29 English
CLARIFICATION ANNOUNCEMENT
Interim / Quarterly Report Classification · 95% confidence The document is a clarification announcement related to a previously released announcement dated 25 April 2014 concerning the unaudited first quarterly results for the three months ended 31 March 2014. It includes a detailed cash flow statement for the period, which is substantive financial data. The document is relatively short (3628 characters) but contains actual financial statements, not just a notice or link to a report. The content aligns with an Interim / Quarterly Report as it covers quarterly financial results with detailed financial data. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2014
2014-04-25 English
RESULTS REPORT FOR THE FIRST QUARTER OF 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RESULTS REPORT FOR THE FIRST QUARTER OF 2014' and contains detailed unaudited financial data and operating performance metrics for the first quarter ending 31 March 2014. It references compliance with disclosure requirements under the Hong Kong Stock Exchange and the China Securities Regulatory Commission (CSRC). The content includes financial statements, segment operating data, shareholder information, and management declarations of accuracy. The document length is substantial (15,000 characters) and contains actual financial data and analysis for a quarterly period, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2014
2014-04-25 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FIRST QUARTER OF 2014 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Yanzhou Coal Mining Company Limited regarding the publication of production and sales volume data for the first quarter of 2014 of its overseas subsidiary, Yancoal Australia Limited. It provides summary production and sales figures but does not contain detailed financial statements or comprehensive analysis. The document references the full report published on the ASX website, indicating that this is a brief announcement rather than the full quarterly report itself. The length is short (2209 characters), and it serves to inform about the availability of data rather than presenting the full report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not meet the criteria for an Interim/Quarterly Report (IR) or Earnings Release (ER).
2014-04-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.